These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Kim J; Yoo SW; Kang SR; Bom HS; Song HC; Min JJ Ann Hematol; 2014 Apr; 93(4):661-7. PubMed ID: 24061788 [TBL] [Abstract][Full Text] [Related]
44. FDG-avid venous malformation could mimic malignancy on 18F-FDG PET/CT. Mojtahedi A; Grewal RK; Ulaner GA Clin Nucl Med; 2013 Oct; 38(10):826-8. PubMed ID: 24107816 [TBL] [Abstract][Full Text] [Related]
45. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma. Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468 [TBL] [Abstract][Full Text] [Related]
46. (18)F-FDG PET/CT findings of obstructive colitis proximal to colorectal cancer. Oh JK; Park HL; Park SY; Lee SH; Han EJ; Chung YA; Kim SH; Park YH Clin Nucl Med; 2014 Feb; 39(2):136-41. PubMed ID: 24300349 [TBL] [Abstract][Full Text] [Related]
47. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
49. Ulaner GA; Castillo R; Wills J; Gönen M; Goldman DA Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1420-1427. PubMed ID: 28456837 [TBL] [Abstract][Full Text] [Related]
50. Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary. Fencl P; Belohlavek O; Skopalova M; Jaruskova M; Kantorova I; Simonova K Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1783-92. PubMed ID: 17541584 [TBL] [Abstract][Full Text] [Related]
51. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis. Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446 [TBL] [Abstract][Full Text] [Related]
52. Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type. Liu C; Zhang Y; Zhang Y; Wang M; Liu R; Liu X; Hu S Nucl Med Commun; 2016 May; 37(5):446-52. PubMed ID: 26657218 [TBL] [Abstract][Full Text] [Related]
54. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation. Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488 [TBL] [Abstract][Full Text] [Related]
55. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT. Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459 [TBL] [Abstract][Full Text] [Related]
56. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors. Al-Bulushi NK; Abouzied ME Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992 [TBL] [Abstract][Full Text] [Related]
58. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I; Sivrikoz MC; Entok E; Vardareli E Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657 [TBL] [Abstract][Full Text] [Related]
59. Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer? Israel O; Mor M; Guralnik L; Hermoni N; Gaitini D; Bar-Shalom R; Keidar Z; Epelbaum R J Nucl Med; 2004 Dec; 45(12):2045-51. PubMed ID: 15585480 [TBL] [Abstract][Full Text] [Related]